COMP <GO>
LSTR vs TMO // PIOTROSKI F-SCORE QUALITY
Landstar System Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: LSTR 6
— TMO 8
▲ PIOTROSKI F-SCORE QUALITY LEADER: TMO
LAST: $142.70 (+0.94%) • MKT CAP: $4.77B
piotroski-score
7/9
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LSTR VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LSTR | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.40% | 9.30% | +7.10 | LSTR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.4x | 30.4x | -1.00 | LSTR | /valuation <GO> |
| Free Cash Flow Yield | 4.51% | 2.40% | +2.11 | LSTR | /fcf-yield <GO> |
| Operating Margin | 3.20% | 17.40% | -14.20 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.40% | 15.10% | -12.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -1.60% | 3.90% | -5.50 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.62% | 0.24% | +2.38 | LSTR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.67 | 4.50 | +5.17 | LSTR | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.70% | -0.20 | LSTR | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 27.9 | 59.1 | -31.30 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.94 | -0.05 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 38.5x | 36.3x | +2.20 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.77B | $262.22B | -$257.45B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LSTR REV | TMO REV | LSTR GROSS % | TMO GROSS % | LSTR FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.74B | $44.56B | 44.0% | 44.0% | $215.0M | $6.29B |
| FY 2024 | $4.82B | $42.88B | 44.0% | 44.0% | $255.6M | $7.27B |
| FY 2023 | $5.30B | $42.86B | 44.0% | 44.0% | $155.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LSTR // BETA 0.89
TMO // BETA 0.94